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ABSTRACT
Isolation and Culture of Satellite Cells from the Extensor Digitorum Longus
Ethan M. Tietze
Peripheral arterial occlusive disease (PAOD) involves distal artery occlusion by
atherosclerotic plaques, which restricts blood flow and leads to ischemia in downstream
tissues. Increased blood flow through preexisting collateral vessels leads to increased
shear stress that triggers an outward remodeling of the vessel called arteriogenesis. In
some cases this natural compensatory mechanism is able to sufficiently restore blood
flow following arterial occlusion. However, for many individuals this process is
insufficient to relieve peripheral ischemia, and patients experience intermittent
claudication, or limb pain with locomotion or exercise. Without treatment, reduced blood
flow can lead to tissue necrosis and potentially amputation. The efficacy of medication,
such as drugs to lower cholesterol, is limited while surgical intervention is only available
to a limited patient population. Supervised exercise therapy can improve important
patient outcomes such as pain-free walking time and distance. Unfortunately, many
patients fail to adhere to regimented exercise programs, limiting its functional efficacy. A
potential alternative treatment approach is to stimulate or enhance arteriogenesis with cell
therapy to recapitulate the beneficial effects of exercise therapy. Following exercise,
resident muscle stem cells known as Satellite Cells (SCs) activate, repairing damaged
muscle fibers and playing an important role in local angiogenesis. They and their progeny
myoblasts, secrete a wide range of factors known to be involved in arteriogenesis and the
recruitment of other cells involved in remodeling. As such, these cells are ideal
candidates for transplantation. Before preliminary evaluation of these myogenic cells can
be performed, a reliable source of these cells is required. Towards this goal, protocols
were developed to obtain cells in sufficient numbers for transplantation. Whole Extensor
Digitorum Longus (EDL) muscles were excised from mouse hindlimbs. Myofibers were
isolated by collagenase digestion and trituration, and placed in specialized culture
conditions to promote the adherence and selective growth of myogenic cells. In these
conditions, SCs activate, migrate from myofibers, and proliferate. With increasing time in
culture, especially following myofiber hypercontraction, SCs increasingly differentiate,
limiting expansion and the availability of cells for transplantation. Future research will
focus on improving culture conditions to inhibit differentiation and maintain sustained
growth to improve the availability and in vivo behavior of isolated cells. Once sufficient
cell numbers are obtained they will be transplanted into a mouse model of chronic
peripheral ischemia to investigate their impact on collateral remodeling.
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Chapter 1: Introduction
1.1 Relevance: Peripheral Arterial Occlusive Disease
Peripheral Arterial Occlusive Disease (PAOD) is an ischemic disease characterized by
the narrowing, or stenosis, of distal arteries, primarily in the lower extremities. Most
commonly stenosis results from atherosclerotic plaques within arterial walls. With
atherosclerotic progression, vessels can become increasing occluded, leading to ischemia
in downstream tissues. Alternatively, thromboembolism can lead to a rapid onset of
ischemic conditions

1–3

. In the United States, over 8 million individuals have PAOD,

with older individuals being disproportionately affected 4,5 ]. Patients with PAOD
commonly present with temporary pain during activities such as walking or exercise,
which is

Figure 1. Peripheral Artery Occlusive Disease. In atherosclerosis, plaques develop
within the walls of conduit arteries reducing blood flow and causing ischemia
downstream tissues6.
6

termed intermittent claudication 2. If left untreated, blood flow can be further reduced
until insufficient oxygen and nutrients are delivered even at rest, which is described as
critical limb ischemia (CLI) 7. Within one year, 30% of individuals undergo amputation
and another 25% of individuals die from coronary heart disease or stroke, which
commonly present with PAOD.8. Although only a small percentage of patients reach this
advanced stage of the disease, up to 50% of patients with PAOD experience leg
symptoms that reduce mobility, leading to reduced reported quality of life, and increased
rates of depression9
First line treatments focus on the reduction risk factors for atherosclerosis, including
cessation of smoking and management of blood pressure and cholesterol10. While these
treatments are relatively low risk, they have a limited ability to address the underlying
problem of reduced peripheral circulation. For example, cholesterol lowering medications
may reduce the likelihood of plaque growth without substantially reducing plaque size11.
Alternatively, surgical or endovascular procedures including bypass grafts and
angioplasty, respectively, can be utilized to restore blood flow 2,10. Unfortunately,
patients only become eligible for these procedures after failure of first line treatments or
in the event of severe claudication leading to CLI 12. Another treatment strategy, often
prescribed as a first line treatment, is the adoption of a regimented exercise program.
Treatment commonly consists of a minimum three month program with increasing
walking times or distances where patients are only allowed to take breaks with the advent
of moderate to severe leg pain 7. Adoption of such a program significantly increases both
pain-free walking time and distance, but its efficacy is limited by poor adherence to
exercise 10,13. Compliance in clinical trials is highly variable with one study reporting
7

compliance as low as 49% 1. Currently, PAD lacks treatment options that both treat the
underlying disease and are available and reasonable for most patients to complete.

1.2 Potential Treatment: Collateral Arteriogenesis
A potential alternative approach for treatment of PAOD is to enhance the growth of
natural bypass vessels within the peripheral circulation14. Some individual arterial trees
are connected via small arteriole anastomoses, i.e. collaterals15. In the distal ischemic
hindlimb, collaterals function as the primary site of flow resistance16. Through a process
known as collateral arteriogenesis, these vessels have the ability remodel into high
conductance, low resistance arterial vessels, a process which can be enhanced with
exercise 17–19.When an arterial vessel is occluded, an increased pressure gradient is
established across collaterals upstream of the occlusion20. As a result, blood flow is
elevated through these collaterals, causing them to act as a natural bypass routes between
adjacent arterial trees20. Simultaneously, increased blood flow increases shear stress,
initiating collateral arteriogenesis20,21. Endothelial cells (ECs) recruit monocytes which
extravasate and differentiate into macrophages that orchestrate degradation of the
extracellular matrix (ECM)22,23 . Additional cytokines released by ECs promote
proliferation of both themselves and smooth muscle cells before new ECM is synthesized
by local cells22,23. When completed, remodeled collaterals have the potential to restore
sufficient perfusion to ischemic tissue downstream of an occlusion.
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Figure 2. Arteriogenesis. Development of atherosclerotic plaques reduce blood flow to
downstream tissues while simultaneously increasing shear stress in pre-existing collateral
arterioles. This high shear condition activates endothelial cells, leading to the outward remodeling
of these bypass vessel and restoring perfusion to affected tissues. 24

Unfortunately, this endogenous mechanism of collateral arteriogenesis fails to
sufficiently restore blood flow for many individuals25. Variation in both the preexisting
collateral network and magnitude of the arteriogenic response varies significantly in
animal models and is suspected to be similarly present with the human population15,25.

1.3 Cell Therapy: Satellite Cell Transplantation
To date, attempts to treat PAOD by augmenting collateral arteriogenesis have proven
unsuccessful. Exercise treatment is efficacious, but poor compliance prevents widespread
implementation ref. Delivery of individual arteriogenic factors (VEGF, bFGF, etc.) using
gene therapy or recombinant proteins have appeared promising in preclinical animal
studies and small uncontrolled clinical trials, but have proven unsuccessful in large,
controlled clinical trials 26,27. Specifically, these therapies failed to improve pain-free
walking distance or ankle brachial index14,28. Alternatively, transplantation of cells
involved in collateral remodeling are being investigated to recapitulate the benefits of
exercise therapy9. Instead of delivering an individual growth factor, these cells can
9

potentially act as “cytokine factories”, producing a wide range of growth factors29. For
example, bone marrow derived cells (BMC) are being investigated due to their
recruitment to collaterals and secretion of a wide variety of cytokines (MCP-1, FGF-2,
TGF-β, uPA, and MMPs) involved in collateral remodeling 29. Another cell type
integrally involved in exercise is the Satellite Cell (SC), the resident stem cell responsible
for the repair and maintenance of skeletal muscle. In response to muscle damage or
exercise, SCs activate and differentiate into highly proliferative muscle precursor cells
(MPCs) also known as myoblasts. With further differentiation, myoblasts exit the cell
cycle and fuse, incorporating into regenerating or repairing myofibers30,31. SCs are
preferentially located near capillaries within skeletal muscle and are implicated in
signaling with endothelial cells to simultaneously promote myogenesis and
angiogenesis32. Additionally, activated SCs and myoblasts secrete a variety of factors
involved in collateral remodeling (MMPs, VEGF) and recruitment of monocytes (MCP1, MDC, FKN)23,31. Therefore, SCs and myoblasts are attractive transplantation
candidates to recapitulate the beneficial effects of exercise to treat PAOD.
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Figure 3. Satellite stem cell niche. Satellite cells are located on the periphery of
myofibers between the basal lamina and sarcolemma in close proximity to the local
microvasculature. Adapted from 33

1.4 Project Objective
To evaluate the potential effects of SC transplantation on arteriogenesis, it is necessary to
establish a reliable method to isolate and culture primary murine SCs. The objective of
this project is to build off previous work conducted to isolate and culture SCs from the
Extensor Digitorum Longus (EDL) hindlimb muscles of mice 15 and establish reliable
protocols to:
1. Excise whole EDL muscles from adult mice
2. Isolate individual viable myofibers from explanted muscles
3. Optimize a primary culture system of live myofibers to allow sufficient expansion
of SCs for transplantation
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Chapter 2: Methods and Results
2.1 Animal Husbandry
Experimental procedures were approved by the Institutional Animal Care and Use
Committee (IACUC) of Cal Poly. Male and Female C57Bl/6 and ICR mice aged between
2-7 months were used for all experiments. Mice were maintained on a 12:12 hour
light:dark cycle with ad libitum access to feed and water.

2.2 Extensor Digitorum Longus Excision
Mice were euthanized by cervical dislocation while anesthetized with 1-3% isoflurane
gas with a flow rate of 0.8-1 l•min-1. Mice were placed in a supine position on a
Styrofoam working surface, all four limbs were pinned to the surface with XXG syringes,
and both hindlimbs were thoroughly disinfected with 70% isopropanol. The skin was
then removed from the knee to the medial aspect of the hindpaw. The distal tendon of the
Tibialis Anterior (TA) and Extensor Digitorum Longus (EDL) were exposed and the
medial aspect of the TA was freed from the tibia by cutting along its length. Next, the TA
was resected and discarded to improve visualization before resecting the EDL. Special
care was taken to ensure that the EDL was minimally damaged throughout the dissection
process. Muscles were only manipulated via the proximal and distal tendons to avoid
contact with the muscle body. To reduce the chance of stretching the muscle,
manipulation under tension was avoided. While grasping the tendon, the muscle belly
was allowed to sag, providing a margin of error before muscle damage would occur.
Loss of fiber integrity at this stage, due to even minor stretching, leads to excessive fiber
death and hypercontraction during subsequent digestion steps34,35.
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Figure 4. Extensor Digitorum Longus excision. (A) Experimental set-up used for the excision
of EDL muscles. Removal of skin of the hindlimb (B) exposes the TA muscle (C, grey arrow)
and distal tendons (D) of the TA (grey arrow) and EDL (black arrow). (E) Excision of the TA (E)
exposes the EDL muscle (black arrow). Handling only the distal tendon, the EDL is gently
excised from tendon to tendon (F)

2.3 Enzymatic Digestion
Excised muscles were immediately placed in a digestion solution (3mL, 2 mg∙mL-1 type 2
collagenase [Worthington CLS-2], 1% Penicillin-Streptomycin [Omega PS-20] in HAMS
F10 [Fisher SH3002501] in a water bath at 37⁰C. Every ten minutes the solution was
inverted to ensure even digestion. Muscles were incubated for 50-70 min depending upon
muscle appearance; after 50 min, muscles were visually inspected every 5 minutes to
avoid over-digestion of the muscle. When an EDL muscle has been properly digested, the
muscle will shorten and widen as individual muscle fibers separate from each other and
13

structural connective tissue degrades. Distinct, shiny myofibers will begin to protrude
from the muscle body. In the case muscles were overdigested, the muscle will appear
fuzzy and milky colored as the surface fibers have died and hypercontracted.

2.4 Mechanical Myofiber Dissociation
All manipulations of muscles or myofibers were carried out using custom, beveled, glass
pipettes coated with horse serum. Horse serum is critical to prevent adhesion of the
myofibers to the pipette. Upon sufficient digestion, muscles were transferred to a 100 mm
tissue culture dish filled with wash media (HAMS F10 supplemented with 10% FBS
[Fisher SH3091003], 1% Pen-Strep) using the largest diameter pipette (4mm i.d.).
Muscles were then washed with media and gently triturated to release individual fibers.
This process was repeated with two progressively smaller pipettes (2, 0.75 mm i.d.
respectively) until all live fibers were harvested. Live and dead/damaged fibers were
distinguished based upon morphology. Live fibers were straight or wavy and appeared
translucent or iridescent depending upon lighting conditions. With sufficient time in
culture, fibers with a wavy appearance adopt a straight appearance. If a fiber was
severely damaged, hypercontraction would occur at the site of injury, appearing as a
widened, milky-colored section of fiber. Often, this leads fibers to have one or more
sharp kinks along their length. In most cases, the area of hypercontraction would extend
along the entire length, leading to death of the fiber. Under a stereo dissecting
microscope, using a horse serum coated P100 pipette, live myofibers were transferred
into a series of five tissue-culture dishes with wash media (20 mL dish 1-2, 10 mL dishes
3-5) to enrich for live fibers and reduce non-myogenic debris. Enriched fibers were plated
14

in a 60 mm tissue culture dish that was previously coated overnight with 1:1 ratio of
collagen I (Fisher CB354249) and laminin (Life Technologies 23017015) and rinsed
three times with wash media. The final plate was filled with 6 mL of wash media
containing 2 ng/mL bFGF (Fisher CB40060), and incubated at 37⁰C with 5% CO2.
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Figure 5. Isolation of live myofibers. (A) Experimental setup used to isolate individual live
myofibers. (B) Complete enzymatic digestion with myofibers protruding from the muscle (black
arrows). (C) Fibers are released from the muscle with mechanical dissociation resulting in (E) a
mixed culture containing both live (black arrows) and dead (white arrows) fibers. Images were
obtained using a stereo dissecting microscope. All scale bars are 500 μm.

2.5 Myofiber Culture
Myofiber cultures were assessed daily using a phase-contrast microscope. Typically,
punitive Satellite Cells began migrating from fibers after two days in culture. Every three
days, media was partially exchanged (~ X%) and supplemented with bFGF (2 ng∙mL-1);
full media exchange was avoided to minimize fiber loss. Cultures were maintained in the
15

initial dish until the majority of myofibers had died or the confluency reached 80%. For
passaging, strong attachment of fibroblasts was exploited to enrich the culture for
myogenic cells. Briefly, the media was aspirated, trypsin was added, and the culture was
placed in the incubator. After one minute, cultures were observed to ensure selective
liberation of myogenic cells (based on morphology) from the dish bottom. Trypsin
(Invitrogen 25300-062) was neutralized with an equal volume of wash media and the cell
suspension was centrifuged at 0.3 rcf for 10 minute. The resulting cell pellet was
resuspended in wash media, and cells were plated onto coated dishes at approximately
20% confluency. Cultures were subsequently passaged upon 80% confluency or after 5
days 36. Myoblasts adopt a spherical or spindle-like morphology upon attaching to the
culture dish becoming increasing differentiated with time in culture (figure 6 D).
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Figure 6. Culture of live myofibers. (A) Representative image of a live myofiber following
isolation. (B) At higher magnifications cell nuclei and striations can be observed (C) punitive
Satellite cells begin to migrate from fibers after 48 hours in culture. (D) With time in culture
myogenic cells become increasingly differentiated appearing increasingly elongated (white
arrows). Representative images were obtained using a phase contrast microscope. All scale bars
are 50 μm.
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Chapter 3: Discussion
3.1 Protocol Development – Extensor Digitorum Longus Excision

PAOD affects over 8 million Americans, commonly causing pain with movement or
exercise that leads to restricted mobility and a lower quality of life. Progression of PAOD
can lead to amputation and is associated with increased risk of mortality. Most widely
available treatments fail to address underlying deficits in peripheral circulation, and
treatments such as exercise therapy which improve collateral circulation have poor
compliance. Cell therapy has been proposed as an alternative strategy to recreate the
beneficial effects observed with exercise. Specifically, the objective of this project was to
isolate and culture myogenic cells for subsequent evaluation of their impact on collateral
arteriogenesis. As a first step, EDL muscles and their proximal and distal tendons were
exposed and subsequently excised. The extent of connective tissue obscuring these
tendons was highly dependent upon mouse age. In young mice both distal tendons could
be easily visualized and accessed with minimal blunt dissection, whereas older mice
required extensive blunt dissection to visualize distal tendons. To reduce the likelihood of
unintentional muscle damage, young mice should be used whenever possible.

3.2 Protocol Development – Isolation of Individual Myofibers
The connective tissue of isolated whole muscles was degraded using a type II
Collagenase solution, based on previous work23. Muscles were incubated without
agitation and periodically mixed to ensure even enzyme coating for uniform muscle
digestion35. Although gentle agitation increases SC activation during digestion of Flexor
Digitorum Brevis muscles, this technique was not utilized37. Access to the necessary
equipment was intermittent and risked cooling the muscle significantly below body
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temperature. Additionally, the culture conditions used are sufficient to activate SCs34,38.
Determination of the appropriate length of digestion proved to be a significant challenge.
If fibers were digested for too short a time, connective tissue would be insufficiently
degraded to allow for liberation of individual fibers from the muscle belly. When
triturating or washing media over the muscle, superficial fibers would only separate if
excessive force was used. Fibers liberated in this manner would commonly die due to
damage inflicted from the process. Simultaneously, deep connective tissue would fail to
be noticeably degraded. In contrast, excessive digestion would severely damage
myofibers leading to a ‘kinked’ morphology. After a short time in culture these fibers die
and develop a hypercontracted appearance34. Fibers were most effectively isolated when
muscles were digested in the collagenase solution until the tips of superficial fibers began
to protrude from the muscle belly. Complicating matters, the time required to reach this
level of digestion was highly dependent upon the muscles’ physical characteristics. EDL
muscles are commonly used to isolate live myofibers due to their thin shape and minimal
connective tissue, both which aid enzymatic digestion. With increasing age, mouse EDL
muscles increase in both collagen content and total volume of connective tissue39. The
EDL muscles of adult mice (5-7 months) are significantly larger than those of young
mice (3 months) 15.4±3.2 mg versus 9.04±0.2 mg respectively40,41. Using the described
digestion conditions, fewer viable myofibers were harvested from older adult C57Bl/6
mice compared with younger mice. Even with longer digestion times larger muscles
failed to digest uniformly. Superficial fibers degraded and died while deep connective
tissue remained intact. A potential explanation was that the digestion used was too
aggressive leading to excessive cellular damage. In future work, this problem may be
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addressed through the use of type I Collagenase, combined with a longer digestion
time42. Type I Collagenase has reduced activity of Clostripain, a proteinase that degrades
at? arginine, making it more suitable for the digestion of delicate tissues such as liver or
adrenal gland43. In fact, some protocols involve the use of type I Collagenase coupled
with a longer digestion to isolate EDL and the larger Tibialis Anterior (TA) muscle34,38.
Alternatively, the working concentration of type II Collagenase could be reduced to
increase digestion uniformity. For either approach, it is important to account for
significant lot-to-lot variation in enzyme activity. In fact Worthington Biochemical, the
supplier of the type II Collagenase, only reports a minimum value of enzymatic activity
and highly recommends sampling multiple lots for ideal digestion characteristics44. As all
these factors modify digestion time, it is important to closely monitor the muscle
digestion process in every procedure.

3.3 Protocol Development – Mechanical Dissociation of Individual Myofibers
Upon complete digestion, muscles were transferred to a fresh tissue culture dish for
mechanical dissociation of individual fibers. As with other steps, significant effort was
made to minimize damage to live myofibers. Surfaces in contact with myofibers were
coated horse serum to minimize adhesion. Media was gently washed over the muscles,
isolating fibers from the muscle body using a wide bore glass pipette. Although some
protocols caution against trituration of the muscle, the technique proved useful for
separating more strongly attached fibers from the muscle belly34. If used, it is critical that
the mouth of the pipette is large enough to allow the muscle to freely enter the pipette
without making contact with the pipette mouth. As fibers liberate from the muscle,
smaller bore glass pipettes maintain trituration intensity. Failure of fibers to separate
20

indicates the muscle was not sufficiently digested or was severely damaged, which
cannot be addressed by increasing the trituration force. Few fibers releasing, with
minimal kinked or hypercontracted fibers, suggests insufficient digestion which can be
rectified by further digesting the muscle in the collagenase solution. On the other hand,
significant debris and hypercontraction suggest excessive fiber damage due to digestion
or surgical error, which cannot be salvaged. If digestion and trituration are performed
effectively, freed myofibers appear shiny and straight or wavy (a wave-like morphology
should become straight after resting in culture overnight). Inevitably, the dissociation
process releases a wide range of undesired cell types, including adipocytes and
fibroblasts. To reduce contamination of the culture with these cells, live myofibers were
identified and repeatedly transferred to fresh culture dishes. Initial use of three transfers
proved insufficient, resulting in cultures with mixed populations of cells. Although
unobservable, free-floating, non-myogenic cells are present in media after 3 washes45.
The addition of two wash steps proved sufficient to significantly reduce contaminating
cells, producing predominantly myogenic cultures45.

3.4 Protocol Development – Live Myofiber Culture
Isolated myofibers were immediately transferred to a culture system to selectively expand
myogenic cells. To efficiently expand these cells, in vitro conditions must be designed to
recapitulate as many aspects as is reasonable of the satellite cell niche. Together, the
media and culture substrate must contain the nutrients, soluble factors, and physical cues
necessary to support cell survival and proliferation. In this culture system, HAMs F10
nutrient mixture was chosen as the media base because it provides a selective growth
advantage for myogenic cells 46. In contrast, in other nutrient mixtures such as DMEM,
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myoblasts expand more quickly, but are quickly outcompeted by fibroblasts.46. Although
precautionary steps were taken to reduce non-myogenic cells, isolated populations of
fibroblasts were still commonly observed, necessitating use of HAMs F10. However,
once a highly myogenic population is established, DMEM could potentially be used to
improve the expansion rate of the culture.
Base media was supplemented with fetal bovine serum (FBS), an essential media
component commonly used to culture myoblasts, that provides a relatively high
concentration of necessary nutrients and growth factors 38,46,47. Myofibers were initially
cultured in media containing 10% FBS, as myofibers survive longer in a relatively low
serum environment38. Under these conditions SCs activate and migrate from fibers. Once
fibers die in culture, the serum concentration was increased to 20% to encourage
proliferation38. Survival of myofibers was prioritized over increased serum concentrations
due to an observed reduction of myoblast proliferation rates following myofiber death,
even with increased serum concentrations. This observation may be explained by a loss
of myofiber-derived growth factors (IGF, EGF, HGF) that encourage proliferation30,31. In
addition to FBS, the culture was supplemented with basic fibroblasts growth factor
(bFGF or FGF2). Found in the basal lamina of skeletal muscle, bFGF is released upon
muscle injury and has been implicated in the activation, proliferation, and reduced
differentiation of SCs 30,31,48.
To facilitate attachment of SCs, culture dishes were coated with two skeletal muscle
ECM proteins, collagen I and laminin. Collagen I is a major structural component of the
ECM that is commonly-chosen culture substrate, and is deposited by myogenic cells in
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vitro46,49. Laminins are glycoproteins that act as linkage molecules between the basal
lamina and sarcolemma transmitting both mechanical forces and chemical signals50.
Interestingly, the enhanced proliferative effects of bFGF are dependent upon interactions
with the ECM, increasing specifically with laminin as a culture substrate48. Broadly,
interactions of SCs with the ECM are implicated in regulating a wide range of satellite
cell behavior30.
Using the described culture conditions myofiber derived cells were consistently
expanded. However, cells began to increasingly exhibit a wide range of morphologies
and variable proliferative potentials with increasing time in culture, an effect that was
accelerated with loss of live myofibers in culture. Some cells retained a compact circular
phenotype characteristic of minimally differentiated cells, while others exhibited an
elongated bipolar phenotype. With increasing differentiation, the proliferative ability of
the cells in culture declined. Once a majority of the cells appeared differentiated, the
culture failed to appreciably expand.

3.5 Future Work
Future work will focus on improving culture conditions to enable long-term expansion of
myogenic cells. Current culture conditions allow for initial expansion followed by a
progressive loss of proliferative potential. Commonly, only 1-2 x105 cells are generated,
limiting the number of transplantation experiments that can be completed with a single
isolation of SCs. Additionally, current conditions result in progressive uncontrolled
differentiation of myogenic cells. When considering cell transplantation, it is important to
consider how in vitro differentiation will affect cellular behavior in vivo. Even three days
in culture resulted in a tenfold reduction in the engraftment efficiency of FACS isolated
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SCs in a dystrophic mouse model51. Similarly, in the context of peripheral ischemia, the
function of transplanted myogenic cells may be reduced with SC differentiation. To
address this concern, a culture system designed to limit differentiation should be
investigated. One particularly interesting approach involves the use of a small molecule
inhibitor of p38 MAPK signaling. p38 MAPK is part of a transcriptional regulatory
network that influences SC self-renewal and differentiation 52. FACs isolated Human SCs
treated with this inhibitor suppressed expression of several differentiation factors while
maintaining exponential growth for three weeks in culture52. When implanted, these cells
demonstrated improved engraftment compared to freshly isolated or standard culture
conditions52. Adaptation of this system to the described single fiber culture has the
potential to prevent in vitro differentiation, allowing long term culture expansion and
improved in vivo behavior of myogenic cells for future transplantation studies.
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Appendix
Muscle Fiber Preparation and Myofiber Isolation
Date: ______________
•
•
•
•
•
•
•
•
•
•
•
•
•

Type II Collagenase
HAMS F10 Nutrient Mixture
Pen-Strep
Horse Serum (HS)
Fetal Bovine Serum (FBS)
Calf Skin Collagen Stock Solution
18 MΩ Water
Glacial Acetic Acid
60 mm Tissue Culture (TC) Dish
100 mm Tissue Culture (TC) Dish
15 mL Conical Tubes
50 mL Conical Tubes
37⁰C Water Bath

•
•
•
•
•
•
•
•
•
•
•
•

Rocking Platform
Sterile PBS
P1000 Micropipette
P1000 Micropipette Tips
Standard Pattern Forceps
Curved Iris Scissors
5/45 Forceps
Beveled Glass Pipettes
Cotton swabs
Cotton patches
500 mL, 0.22 µm Vacuum Filter System
Isopropyl Alcohol (IPA)

Muscle Fiber Wash Plates
1. ___ Defrost aliquot of HS
2. ___ In TC hood, Coat 5x 100 mm TC dishes in HS
a. Label TC dishes 1-5
b. Pipette 7 mL of HS into first TC dish
c. Transfer HS between dishes
d. Place remaining HS in 15 mL conical and place in 37⁰C water bath
e. Aspirate excess HS from TC dishes
3. ___ Place 20 mL of wash media into Dishes 1-2
4. ___ Place 10 mL of wash media into Dishes 3-5
5. ___ Warm plates in 37⁰C, 5% CO2 incubator
Muscle Excision – Extensor Digitorum Longus (EDL)
1.
2.
3.
4.
5.
6.
7.
8.
9.

___ Euthanize mouse
___ Use insulin syringe needles to secure fore and hind limbs to Styrofoam working surface
___ Thoroughly spray hindlimbs with IPA
___ Carefully remove the skin of both hindlimbs
a. The hindlimb should be exposed from the knee joint to the midpoint of each foot
___ Carefully remove connective tissue around the Tibialis Anterior (TA) Muscle
a. Make sure to expose the origin of the EDL at the knee
___ Create a pocket deep to the distal TA tendon below the ankle
___ Cut the distal TA tendon
___ Holding the TA by its distal tendon, pull it towards the knee cutting away connective tissue
as needed to separate it from the EDL
___ Cut the TA at its origin and set aside to expose the EDL
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10. ___ Create a pocket deep to the distal EDL tendon
11. ___ Cut the Distal EDL tendon
12. ___ Holding the cut tendon, carefully pull EDL towards the knee separating it from the
surrounding tissue
a. Avoid stretching the muscle as it will damage individual myofibers
13. ___ Cut the proximal EDL tendon
a. Tendon to Tendon isolation is critical to maintain fiber integrity
14. ___ Place EDL muscle into 3.0 mL of collagenase solution
15. ___ Repeat process for contralateral hindlimb
Muscle Digestion
1. ___Place 15 mL conical with EDL muscles and collagenase in 37⁰C water bath
2. ___ Repeatedly invert the 15 mL conical for every 10 min of incubation
3. ___ Incubate for 40 min
a. Digestion can take between 50-70 min depending upon collagenase activity
4. ___ Following 50 min, remove 15 mL conical every 5 min and inspect for proper digestion
a. Use dissecting microscope light on brightest setting for lighting
b. When properly digested individual myofibers should begin to protrude from the surface
of the muscle belly
c. If the muscle appears fuzzy under a dissecting microscope or individual fibers appear fat
and milky in color, the muscle has been overdigested
5. ___ Upon proper digestion level, remove 15 mL conicals with HS and muscles from the water
bath
6. ___ Spray conicals down with IPA
7. ___ Remove dish 1 from incubator
8. ___ Coat glass pipettes in HS
9. ___ Use glass pipettes to remove muscles from the 15 mL conical and transfer into the first dish
a. Place both muscles into the first dish
b. Place collagenase solution back into the incubator (in case further digestion is needed)
10. ___ Use glass pipettes to dissociate muscles
a. Progressively use smaller bevel pipettes as the muscle becomes more dissociated
b. The muscle should only be washed with media or gently triturated
11. ___ Coat P1000 pipette tips with HS
12. ___ Use a dissecting scope and P1000 pipette to pick out individual live myofibers from the dish
a. Live myofibers will appear shiny or clear and be straight or crinkly
b. Dead myofibers will appear opaque and bent or short
13. ___ Place all live fibers in the next numbered dish
a. Muscles should not remain out of the incubator for more than 15 min
14. ___ Repeat transfer process for the other wash dishes
15. ___ Transfer fibers as described into the collagen and laminin coated dish
16. ___ In the TC hood, add FGF-2 to the dish to a final concentration of 2 ng/mL
17. ___ Place final dish back in the incubator
a. Myoblasts should begin to migrate from the myofibers within 3 days
18. ___ Passage cells upon local confluence or average 80% confluence
Notes:_______________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
_____________________________________________________________________________________
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